- Home
- EVOK vs YCBD Comparison
EVOK vs YCBD Comparison
Compare EVOK & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- YCBD
- Stock Information
- Founded
- EVOK 2007
- YCBD 2015
- Country
- EVOK United States
- YCBD United States
- Employees
- EVOK N/A
- YCBD N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- YCBD Biotechnology: Pharmaceutical Preparations
- Sector
- EVOK Health Care
- YCBD Health Care
- Exchange
- EVOK Nasdaq
- YCBD Nasdaq
- Market Cap
- EVOK 7.6M
- YCBD 7.8M
- IPO Year
- EVOK 2013
- YCBD N/A
- Fundamental
- Price
- EVOK $5.15
- YCBD $0.87
- Analyst Decision
- EVOK
- YCBD Strong Buy
- Analyst Count
- EVOK 0
- YCBD 1
- Target Price
- EVOK N/A
- YCBD $2.00
- AVG Volume (30 Days)
- EVOK 26.0K
- YCBD 531.7K
- Earning Date
- EVOK 11-07-2025
- YCBD 12-17-2025
- Dividend Yield
- EVOK N/A
- YCBD N/A
- EPS Growth
- EVOK N/A
- YCBD N/A
- EPS
- EVOK N/A
- YCBD N/A
- Revenue
- EVOK $12,794,859.00
- YCBD $19,026,064.00
- Revenue This Year
- EVOK $57.38
- YCBD $0.37
- Revenue Next Year
- EVOK $59.57
- YCBD $4.95
- P/E Ratio
- EVOK N/A
- YCBD N/A
- Revenue Growth
- EVOK 70.02
- YCBD N/A
- 52 Week Low
- EVOK $1.94
- YCBD $0.59
- 52 Week High
- EVOK $9.88
- YCBD $6.54
- Technical
- Relative Strength Index (RSI)
- EVOK 57.04
- YCBD 40.68
- Support Level
- EVOK $4.53
- YCBD $0.94
- Resistance Level
- EVOK $5.19
- YCBD $1.09
- Average True Range (ATR)
- EVOK 0.28
- YCBD 0.13
- MACD
- EVOK 0.07
- YCBD -0.05
- Stochastic Oscillator
- EVOK 91.26
- YCBD 4.45
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.